Janus Henderson Group plc 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 12:28 pm Purchase |
2025-03-31 | 13G | Entrada Therapeutics, Inc. TRDA |
JANUS HENDERSON GROUP PLC JHG |
2,121,654 5.600% |
41,287 (+1.98%) |
Filing |
| 2025-02-14 11:25 am Purchase |
2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
JANUS HENDERSON GROUP PLC JHG |
2,080,367 5.600% |
2,080,367 (New Position) |
Filing |